EUVIMEDEUVIMED entdecken
Crossref

Deslorelin Implant in a Labrador Retriever with Canine Hypersensitivity-Hyperactivity Syndrome (HSHA): Differential Diagnosis, Benefits and Cautions

Marie Lacoste, Sylvia Masson

Animal Behaviour and Welfare Cases · 06.08.2026

DOI: 10.1079/abwcases.2026.0020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Behaviour and Welfare Cases, online erschienen am 06.08.2026. Verfasst von Marie Lacoste und 1 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Gefördert von: The authors have no funders to declare..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canine hypersensitivity hyperactivity syndrome (HSHA) is a neurodevelopmental behavioural disorder characterized by impaired inhibitory control, hyperactivity, hypersensitivity and attention deficit. This case report describes the long-term management of Snoopy, an intact male Labrador Retriever, a family dog undergoing training as a seizure-detection dog, presenting hypersensitivity, hyperreactivity, and impaired attention. The most clinically impactful signs were apparent absence of satiety, ingestion of non-edible items and severe sleep reduction. A multimodal approach combining pharmacological treatment with fluoxetine and structured behavioural therapy resulted in marked and sustained improvement. However, a behavioural deterioration emerged during adolescence, with new behaviours suggesting a hormonal influence on the clinical presentation. The use of a reversible deslorelin implant led to rapid behavioural stabilization, which was consistent with the hypothesis that this was not merely an HSHA relapse. However, increased food-seeking behaviour and weight gain were observed. After discontinuation of hormonal suppression, behavioural stability was maintained, body weight returned to the pre-implant baseline, and pharmacological treatment was progressively withdrawn. This case highlights the importance of long-term follow-up, adaptive therapeutic strategies, and the potential clinical utility of reversible hormonal interventions in the management of canine behavioural disorders. Information © The Authors 2026

Förderung

  • The authors have no funders to declare.

Zitieren

APA

Lacoste, M., & Masson, S. (2026). Deslorelin Implant in a Labrador Retriever with Canine Hypersensitivity-Hyperactivity Syndrome (HSHA): Differential Diagnosis, Benefits and Cautions. Animal Behaviour and Welfare Cases. https://doi.org/10.1079/abwcases.2026.0020

Vancouver

Lacoste M, Masson S. Deslorelin Implant in a Labrador Retriever with Canine Hypersensitivity-Hyperactivity Syndrome (HSHA): Differential Diagnosis, Benefits and Cautions. Animal Behaviour and Welfare Cases. 2026. doi:10.1079/abwcases.2026.0020

BibTeX
@article{Lacoste2026,
  author = {Lacoste, Marie and Masson, Sylvia},
  title = {Deslorelin Implant in a Labrador Retriever with Canine Hypersensitivity-Hyperactivity Syndrome (HSHA): Differential Diagnosis, Benefits and Cautions},
  journal = {Animal Behaviour and Welfare Cases},
  year = {2026},
  doi = {10.1079/abwcases.2026.0020}
}
Kostenlos starten →